SAGCX
Price
$132.17
Change
-$0.30 (-0.23%)
Updated
Jun 2 closing price
Net Assets
4.25B
VSMPX
Price
$341.82
Change
+$0.83 (+0.24%)
Updated
Jun 2 closing price
Net Assets
2.2T
Interact to see
Advertisement

SAGCX vs VSMPX

Header iconSAGCX vs VSMPX Comparison
Open Charts SAGCX vs VSMPXBanner chart's image
SAGCX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
SAGCX vs. VSMPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGCX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.2T vs. SAGCX (4.25B). VSMPX pays higher dividends than SAGCX: VSMPX (1.02) vs SAGCX (0.00). SAGCX was incepted earlier than VSMPX: SAGCX (33 years) vs VSMPX (11 years). SAGCX (1.86) is less costly to investors than VSMPX (0.02). SAGCX is a more actively managed with annual turnover of: 26.00 vs. VSMPX (3.00). SAGCX has a lower initial minimum investment than VSMPX: SAGCX (1000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 27.71 vs. SAGCX (-75.74). VSMPX return over 5 years is better than : 71.45 vs. SAGCX (-93.53).
SAGCXVSMPXSAGCX / VSMPX
Total Expense Ratio1.860.029,300%
Annual Report Gross Expense Ratio1.860.029,300%
Fund Existence33 years11 years-
Gain YTD3.79211.65933%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.25B2.2T0%
Annual Yield % from dividends0.001.02-
Returns for 1 year-75.7427.71-273%
Returns for 3 years-84.8376.50-111%
Returns for 5 years-93.5371.45-131%
Returns for 10 years-94.64250.19-38%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEF63.461.06
+1.70%
Greif
SWBI15.310.17
+1.12%
Smith & Wesson Brands
GHG1.25-0.01
-0.79%
GreenTree Hospitality Group Ltd
WST312.17-4.13
-1.31%
West Pharmaceutical Services
CANF3.11-0.13
-4.01%
Can-Fite Biopharma Ltd